Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP398959.RAm-emAdA4r0VhG2Ajn6pcJdJlGC4eudyuT7t16vuXxsI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP398959.RAm-emAdA4r0VhG2Ajn6pcJdJlGC4eudyuT7t16vuXxsI130_assertion type Assertion NP398959.RAm-emAdA4r0VhG2Ajn6pcJdJlGC4eudyuT7t16vuXxsI130_head.
- NP398959.RAm-emAdA4r0VhG2Ajn6pcJdJlGC4eudyuT7t16vuXxsI130_assertion description "[To determine if mutation of HGF/MET pathway genes is a mechanism for pathway dysregulation, we conducted a mutational analysis by exon resequencing of three key components of this pathway, including serine protease inhibitor Kunitz-type 1 (SPINT1), serine protease inhibitor Kunitz-type 2 (SPINT2), and MET, in 32 primary human medulloblastoma specimens.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP398959.RAm-emAdA4r0VhG2Ajn6pcJdJlGC4eudyuT7t16vuXxsI130_provenance.
- NP398959.RAm-emAdA4r0VhG2Ajn6pcJdJlGC4eudyuT7t16vuXxsI130_assertion evidence source_evidence_literature NP398959.RAm-emAdA4r0VhG2Ajn6pcJdJlGC4eudyuT7t16vuXxsI130_provenance.
- NP398959.RAm-emAdA4r0VhG2Ajn6pcJdJlGC4eudyuT7t16vuXxsI130_assertion SIO_000772 22447520 NP398959.RAm-emAdA4r0VhG2Ajn6pcJdJlGC4eudyuT7t16vuXxsI130_provenance.
- NP398959.RAm-emAdA4r0VhG2Ajn6pcJdJlGC4eudyuT7t16vuXxsI130_assertion wasDerivedFrom befree-20140225 NP398959.RAm-emAdA4r0VhG2Ajn6pcJdJlGC4eudyuT7t16vuXxsI130_provenance.
- NP398959.RAm-emAdA4r0VhG2Ajn6pcJdJlGC4eudyuT7t16vuXxsI130_assertion wasGeneratedBy ECO_0000203 NP398959.RAm-emAdA4r0VhG2Ajn6pcJdJlGC4eudyuT7t16vuXxsI130_provenance.